Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.

類似資料

• Transient and Persistent Hypercalcaemia in Patients Treated by Maintenance Haemodialysis
  著者:: Wing, A. J., 等
  出版事項: (1968)
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
  著者:: Slatopolsky, E, 等
  出版事項: (1984)
• Survival in 200 patients treated by haemodialysis and renal transplantation.
  著者:: Henari, F Z, 等
  出版事項: (1977)
• Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.
  著者:: Cundy, T, 等
  出版事項: (1982)
• Mild asymptomatic hyperparathyroidism.
  著者:: Stevenson, J C, 等
  出版事項: (1980)